In today’s competitive and dynamic clinical research environment, sponsors in Korea are increasingly challenged to recruit and retain qualified clinical research professionals. Limited talent pools, high employee turnover and budgetary constraints make it difficult for sponsors to maintain the high-quality talent required to effectively achieve their clinical development objectives. At the same time, the demand for specialized expertise and operational flexibility continues to rise as clinical trials become increasingly complex and timelines tighten.
This webinar will explore how ICON’s Functional Service Provider (FSP) model, delivered through its Strategic Solutions division, can provide sponsors with a strategic, cost-effective and scalable solution to these challenges. The FSP model enables sponsors to access dedicated, high-performing professionals who are trained, managed and supported by ICON, while being seamlessly integrated into the sponsor’s teams and workflows. This approach allows sponsors to maintain control over their operations while also benefiting from ICON’s operational efficiency, oversight and global best practices as a leading service provider.
The featured speakers will demonstrate how ICON’s ISS (FSP) services offer significant advantages over direct internal recruitment, including enhanced resource flexibility, reduced administrative burden, improved retention through defined career development pathways and access to a global talent network with deep therapeutic expertise. Additionally, this session will highlight internal processes, governance structures and quality management systems that ensure consistent performance and alignment with sponsor expectations.
The webinar will share practical insights and lessons learned from ICON’s extensive experience supporting sponsors in Korea, including examples of how specific market challenges have been addressed and how emerging opportunities have been leveraged. Attendees will leave with a clear understanding of how ICON’s FSP model can help overcome recruitment and retention barriers, optimize resource utilization and support the achievement of clinical research goals more effectively and efficiently.
Register for this webinar to learn how ICON’s FSP services model supports clinical research in Korea by addressing recruitment and retention challenges.
*The webinar will be presented in Korean.
Speakers

(Moderator) Julian Song, Director, Business Development, ICON
Julian Song has over 10 years of experience in the pharmaceutical industry, with eight years in Business Development at different CROs. He is experienced in Phase I-IV studies across various therapeutic areas, with studies conducted in the US, Europe and APAC.

Hyunju Park, Director, Clinical Operations, ICON
Hyunju Park has a Bachelor of Nursing and an MBA and is a certified lecturer of KoNECT. She began her career in the clinical research industry in 2002 and worked for multiple global pharma/CROs for over eight years in FSP services. Currently, she oversees all FSP regional account programs operating in APAC, excluding China and Japan.

May Cho, Talent Acquisition Team Lead, APAC, ICON
May Cho has worked at ICON for approximately 10 years, covering both full-service and FSP business models. She has regional experience across India, Korea, Taiwan, Hong Kong and Thailand.
Who Should Attend?
This webinar will appeal to:
- Sponsors facing challenges in recruiting high-quality talent
- Sponsors struggling with employee retention
- Sponsors reluctant to hire permanent staff due to budget constraints
What You Will Learn
Attendees will gain insight into:
- How ICON Strategic Solutions (ISS) delivers FSP services that outperform direct internal recruitment
- Advantages of ICON’s internal processes, oversight and workforce governance
- Practical examples of resolving clinical workforce challenges in Korea
- Strategies for accessing specialized talent while retaining operational control
Xtalks Partner
ICON
ICON plc is a world-leading clinical research organization powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,250 employees in 97 locations in 55 countries as at March 31, 2025. For further information about ICON, visit: www.iconplc.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account